|
![]() |
|
|
Other Lung Conditions
New Developments in Hormone Replacement TherapyIn July 2002, the government halted a major study of hormone therapy three years early because of a slight but significant increase in the risk of invasive breast cancer. Researchers concluded that the long-term risks of taking hormones outweigh the benefits for a woman who still has her uterus. More than 16,000 women took part in the study, known as the Women's Health Initiative, the largest to compare postmenopausal hormones with a placebo. The therapy was a combination of estrogen and progestin (Prempro), a treatment used by an estimated six million women to replace the declining levels of hormones at menopause. The study sought to determine whether this combination hormone therapy could prevent such ailments as osteoporosis and heart disease. But while there were small decreases in hip fractures and colorectal cancer, the increases in breast cancer, heart attacks, strokes, and blood clots were too unsettling. The data suggested that for every 10,000 women on the estrogen-progestin combination, an additional 8 will develop invasive breast cancer, when compared with women not taking the therapy. An additional 7 will have cardiovascular disease, 8 will have a stroke, and 8 will have blood clots in the lungs (pulmonary embolism). In the aftermath of the trial, it seems that many doctors will be reconsidering prescribing estrogen and progestin. Some women may want to lower their doses or limit the duration of the use of these combinations, while others will elect to try other treatments to combat their hot flashes, vaginal dryness, and other menopausal symptoms. However, it is important for women already on hormone replacement therapy (HRT) to know that there is no urgency to stop, and waiting until an annual exam to discuss it with a doctor is fine. There is also no harm in stopping immediately, if a woman is more comfortable doing so. It's important to remember that only combination therapy appears to have these effects. Estrogen alone taken by women who have had a hysterectomy has not displayed such risks. A separate trial, with 10,000 women who have had a hysterectomy randomly assigned to either estrogen or a placebo, has not indicated an increased breast cancer risk. The trial is scheduled to go until 2005. The full report on the Women's Health Initiative appeared in the Journal of the American Medical Association on July 17, 2002. July 2002 Update Reducing Your Risk of Deep Vein Thrombosis During Airline TravelDeep vein thrombosis (DVT), recently featured in the news as "economy
class syndrome," is the formation of a blood clot in the deep veins
of the legs while sitting particularly in the cramped seats of
an airplane (be it economy class or first class), car, bus, or train
for long periods. You move less in tight quarters, causing circulation
to decrease and allowing blood to collect and form a clot. The blood
clot may cause pain and swelling in the legs. Serious, even fatal complications
can occur if the blood clot breaks loose in the blood stream and travels
to the heart or lungs. Older people, and those who are obese or have
a family history of DVT tend to be at the highest risk.
Studies do not agree on how long a flight needs to be to pose a risk
of blood clotting. A few studies even suggest that there is no association
between blood clots and air travel. Clearly, more research is necessary.
However, while we wait for a definitive answer to these questions, heeding
these simple instructions may help prevent problems. Lung Volume Reduction Surgery for Patients with Severe EmphysemaIn recent years, thousands of patients with severe emphysema have undergone
lung volume reduction surgery even though private insurers and governmental
organizations have questioned the benefits of the treatment. Physicians
believe, however, that removal of the most damaged areas of the lung
allows the rest of the lung to work more efficiently. Now, the results
of a clinical study confirm the benefits of the treatment. |
|||||||||||||||||||||||||||||||||||||||||||||
|
©2000–2006 President & Fellows of Harvard College |
||||||||||||||||||||||||||||||||||||||||||||||
| [ close window ] | |